Cleared Traditional

K123566 - SYNAPSE 3D COLON ANALYSIS

K123566 is the FDA 510(k) clearance for SYNAPSE 3D COLON ANALYSIS by Fujifilm Medical Systems U.S.A, Inc.. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 63-day FDA review.

K123566 · Fujifilm Medical Systems U.S.A, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2013
Decision
63d
Days
Class 2
Risk

K123566 is an FDA 510(k) clearance for the SYNAPSE 3D COLON ANALYSIS. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Fujifilm Medical Systems U.S.A, Inc. (Stamford, US). The FDA issued a Cleared decision on January 22, 2013 after a review of 63 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Fujifilm Medical Systems U.S.A, Inc. devices

Submission Details

510(k) Number K123566 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 20, 2012
Decision Date January 22, 2013
Days to Decision 63 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
44d faster than avg
Panel avg: 107d · This submission: 63d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1096
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K123566.
4MP COLOR LCD MONITOR, RADIFORCE RX440
K130070 · Eizo Nanao Corporation · Feb 2013
CORONIS FUSION 6MP
K130103 · Barco N.V. · Feb 2013
SYNGO, BREAST CARE
K123420 · Siemens Medical Solutions USA, Inc. · Feb 2013
SYNGO.VIA MI WORKFLOWS
K123577 · Siemens Medical Solutions USA, Inc. · Jan 2013
CARDIAC VX
K121762 · Ge Medical Systems, LLC · Jan 2013
SYNGO DYNAMICS
K123922 · Siemens Medical Solutions USA, Inc. · Jan 2013